Lv13
60 积分 2026-01-26 加入
The immune microenvironment of colorectal cancer
2小时前
已完结
A phase I clinical trial of autologous chimeric antigen receptor (CAR) T cells genetically engineered to secrete IL-12 and to target the MUC16ecto antigen in patients (pts) with MUC16ecto+ recurrent high-grade serous ovarian cancer (HGSOC)
1天前
已完结
皖公网安备34019202002308
